Alzheimer's disease, a neurodegenerative condition, manifests through complex pathogenic processes. It primarily involves the accumulation of beta-amyloid plaques outside neurons and tau protein tangles inside neurons. These abnormalities disrupt neuronal communication, leading to cognitive decline and memory loss. The exact cause remains elusive, but genetic factors (like mutations in APP, PSEN1, PSEN2 genes) and environmental influences (such as lifestyle and cardiovascular health) play significant roles. Inflammation and oxidative stress further exacerbate neuronal damage. As the disease progresses, brain regions responsible for memory and cognitive function, like the hippocampus and cerebral cortex, shrink. Early detection through biomarkers and imaging techniques aids in managing symptoms and potentially slowing progression, highlighting ongoing research into treatments targeting these underlying mechanisms.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States